RETRACTION: Establishment and Characterization of a Recurrent Osteosarcoma Cell Line: OSA 1777.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 40772425.
- Also identified by DOI 10.1002/jor.70025.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
P. Thanindratarn, X. Li, D. C. Dean, S. D. Nelson, F. J. Hornicek, and Z. Duan "Establishment and Characterization of a Recurrent Osteosarcoma Cell Line: OSA 1777," Journal of Orthopaedic Research 38, no. 4 (2020): 902-901, https://doi.org/10.1002/jor.24528. The above article, published online on 18 November 2019 in Wiley Online Library (wileyonlinelibrary.com), has been retracted by agreement between the authors; the journal Editor-in-Chief, Edward Schwarz; The Orthopaedic Research Society; and John Wiley & Sons, Inc. US. The authors requested their article be retracted after they learned that the cell line, OSA 1777, had become contaminated with synovial sarcoma cell line SYO-1. It is unknown at what stage the cell line was contaminated, but as a result, the reported results and conclusions are no longer reliable. Therefore, the article must be retracted.